BlackRock, Inc. 13D and 13G filings for Soleno Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-05 5:28 pm Sale | 2024-12-31 | 13G | Soleno Therapeutics, Inc. SLNO | BlackRock Inc. BLK | 2,009,790 4.700% | -2,027 (-0.10%) | Filing |
| 2024-10-24 4:44 pm Purchase | 2024-09-30 | 13G | Soleno Therapeutics, Inc. SLNO | BlackRock Inc. BLK | 2,011,817 5.200% | 2,011,817 (New Position) | Filing |